ALKERGOT Drug Patent Profile
When do Alkergot patents expire, and when can generic versions of Alkergot launch?
Alkergot is a drug marketed by Sandoz and is included in two NDAs.
The generic ingredient in ALKERGOT is ergoloid mesylates. There is one drug master file entry for this compound. Additional details are available on the ergoloid mesylates profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ALKERGOT?
- What are the global sales for ALKERGOT?
- What is Average Wholesale Price for ALKERGOT?
Summary for ALKERGOT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| DailyMed Link: | ALKERGOT at DailyMed |
US Patents and Regulatory Information for ALKERGOT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | ALKERGOT | ergoloid mesylates | TABLET;SUBLINGUAL | 085153-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | ALKERGOT | ergoloid mesylates | TABLET;SUBLINGUAL | 087417-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
